Profound Medical
$6.9
2
+$0.03+0.44% Today
Statistics
Day High
6.98
Day Low
6.8
52W High
8.65
52W Low
3.87
Volume
38,787
Avg. Volume
-
Mkt Cap
250.43M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30JulExpected
Expected EPS
-0.326683
Actual EPS
N/A
Financials
-260.45%Profit Margin
Unprofitable21.36MRevenue
-55.63MNet Income
Analyst Ratings
12Average Price Target
The highest estimate is 12.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PROF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
EDAP TMS.
EDAP
Mkt Cap161.17M
Intuitive Surgical
ISRG
Mkt Cap155.16B
Medtronic
MDT
Mkt Cap100.91B
Boston Scientific
BSX
Mkt Cap85.88B
Globus Medical
GMED
Mkt Cap11.51B
Stryker
SYK
Mkt Cap121.33B
Zimmer Biomet
ZBH
Mkt Cap16.54B
Johnson & Johnson
JNJ
Mkt Cap564.11B
Abbott Laboratories
ABT
Mkt Cap152.25B
About
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Show more...
CEO
Dr. Arun Swarup Menawat MBA, Ph.D.
Employees
142
Country
Canada
ISIN
CA74319B5027
Listings
0 Comments
Share your thoughts
FAQ
What is Profound Medical stock price today?▼
The current price of PROF is $6.9 USD — it has increased by +0.44% in the past 24 hours. Watch Profound Medical stock price performance more closely on the chart.
What is Profound Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Profound Medical stocks are traded under the ticker PROF.
Is Profound Medical stock price growing?▼
PROF stock has fallen by -1% compared to the previous week, the month change is a +2.99% rise, over the last year Profound Medical has showed a +31.68% increase.
What is Profound Medical market cap?▼
Today Profound Medical has the market capitalization of 250.43M
When is the next Profound Medical earnings date?▼
Profound Medical is going to release the next earnings report on July 30, 2026.
What were Profound Medical earnings last quarter?▼
PROF earnings for the last quarter are -0.19 USD per share, whereas the estimation was -0.25 USD resulting in a +24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Profound Medical revenue for the last year?▼
Profound Medical revenue for the last year amounts to 21.36M USD.
What is Profound Medical net income for the last year?▼
PROF net income for the last year is -55.63M USD.
How many employees does Profound Medical have?▼
As of May 28, 2026, the company has 142 employees.
In which sector is Profound Medical located?▼
Profound Medical operates in the Health & Wellness sector.
When did Profound Medical complete a stock split?▼
The last stock split for Profound Medical was on October 16, 2019 with a ratio of 1:10.
Where is Profound Medical headquartered?▼
Profound Medical is headquartered in Mississauga, Canada.